SCHEMBL4925336

SCHEMBL4925336

COc1cc(OC)cc(-c2cccc3c(N)c4c(nc23)CN(C)C4=O)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HRH4 Q9H3N8 1/20 0.40
▸ ENPP1 P22413 1/20 0.37
▸ FGFR1 P11362 1/20 0.36
▸ FGFR2 P21802 1/20 0.36
▸ FGFR4 P22455 1/20 0.36
▸ FGFR3 P22607 1/20 0.36
▸ ADORA2A P29274 1/20 0.36
▸ ADORA1 P30542 1/20 0.36
▸ MAPKAPK2 P49137 1/20 0.36
▸ BRD4 O60885 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ BACE1 P56817 4/20 0.34
▸ ABL1 P00519 1/20 0.34
▸ ABCB1 P08183 1/20 0.34
▸ BCR P11274 1/20 0.34
▸ ALOX5 P09917 1/20 0.33
▸ LCK P06239 1/20 0.33
▸ BTK Q06187 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4921019 0.93 HRH4 (0.37) HRH4ENPP1ADORA2AADORA1MAPKAPK2
SCHEMBL4920722 0.87 KDM4E (0.43) HRH4ENPP1FGFR1FGFR2FGFR4
SCHEMBL2661141 0.87 PDE5A (0.40) HRH4ENPP1FGFR1FGFR2FGFR4
SCHEMBL2660620 0.86 GABRG2 (0.41) HRH4ENPP1MAPKAPK2KDM4ELCK
SCHEMBL4923143 0.85 ALDH1A1 (0.39) HRH4ADORA2AADORA1KDM4EALDH1A1
SCHEMBL4916340 0.85 CRHR1 (0.44) KDM4EALDH1A1BACE1
SCHEMBL2661938 0.84 GABRG2 (0.38) HRH4ENPP1KDM4EALDH1A1
SCHEMBL2661488 0.84 GRM2 (0.41) HRH4
SCHEMBL2656734 0.82 BACE1 (0.38) ADORA2AADORA1MAPKAPK2ALDH1A1BACE1
SCHEMBL2655674 0.81 GABRA1 (0.46) ADORA2AMAPKAPK2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080318943-A1 Compounds and Uses Thereof - 848 ASTRAZENECA AB (SE) 2008-12-25 — — US claimed
US-20080318943-A1 Compounds and Uses Thereof - 848 ASTRAZENECA AB (SE) 2008-12-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080318943-A1 Compounds and Uses Thereof - 848 COMT, BACE1, BDNF HRH4 167/4885ENPP1 3350/4885FGFR1 2218/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback